Who is sponsoring NCT05474677?

NCT05474677 is sponsored by Raya Al shaaibi.

What drugs are being tested in NCT05474677?

Interventions in NCT05474677: closure of the abdominal fascia.

What condition does NCT05474677 study?

NCT05474677 studies Suture Size, Incisional Hernia.

Is NCT05474677 still recruiting?

NCT05474677 is currently status unknown. Last updated 3 August 2022.

Last reviewed 2022-08-03 · How we verify

NCT05474677

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Suture Size in Laparotomy Wound Closure to Prevent Post-operative Complications

Status unknown NA Last updated 3 August 2022

What this trial tests

NA trial testing closure of the abdominal fascia in Suture Size, Incisional Hernia in 276 participants. Status unknown.

Timeline

1 August 2022

Primary endpoint
1 January 2025

1 January 2025

Quick facts

Lead sponsor	Raya Al shaaibi
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	276
Start date	1 August 2022
Primary completion	1 January 2025
Estimated completion	1 January 2025
Sites	1 location across Oman

Drugs / interventions tested

closure of the abdominal fascia

Conditions studied

Suture Size, Incisional Hernia — all drugs for Suture Size, Incisional Hernia →

Sponsor

Raya Al shaaibi

Who can join

Adults 18 to 80, any sex, with Suture Size, Incisional Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Incisional hernia is a common complication of midline laparotomy, and it is associated with high morbidity and high costs. Suture size used in the closure of the abdominal wall fascia was not studied independently. Objective: Identify the best suture size for closure of the fascia following laparotomy incisions, by assessing the suture size 2\\0 versus zero. Research methods: Prospective, multicentric, randomized controlled and double-blind trial. Patients undergoing elective or emergency laparotomy in Royal Hospital, Sultan Qaboos University Hospital and Armed Force Hospital between 2022 and 2023. We aimed for a total of 276 patients (n=138 per group). The abdomen will be closed in intervention group with continuous PDS 2\\0 sutures and size zero in control group. Patients will be followed for immediate post-operative wound complications and late complication after 6 months then after one year.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05474677 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Raya Al shaaibi
Last refreshed: 3 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05474677.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing